FDA OKs High-Concentration of Adalimumab Biosimilar Cyltezo
02-05-2024 18:34 via medscape.com

FDA OKs High-Concentration of Adalimumab Biosimilar Cyltezo

Unlike the low-concentration formulation of adalimumab-adbm, launched July 1, 2023, this high-concentration version has not yet been granted an interchangeability designation.Medscape Medical News
Read more »

Nurse news



Fluoride, Water, and Kids' Brains: It's Complicated
Fluoride, Water, and Kids' Brains: It's Complicated
Brain Health and the Need for Preventive Neurology
Brain Health and the Need for Preventive Neurology
AAP Shifts Stance on Breastfeeding With HIV
AAP Shifts Stance on Breastfeeding With HIV
Cannabis Counseling Scarce During Pregnancy, Even for Users
Cannabis Counseling Scarce During Pregnancy, Even for Users
The Lure of Specialty Medicine Pulls NPs From Primary Care
The Lure of Specialty Medicine Pulls NPs From Primary Care
Do You Really Know a UTI When You See It?
Do You Really Know a UTI When You See It?
Chart Review Highlights Unique AD Features in Older Patients
Chart Review Highlights Unique AD Features in Older Patients
Study Identifies Several Onychomycosis Risk Factors
Study Identifies Several Onychomycosis Risk Factors
New Mental Health Strategy Seeks to Curb Maternal Deaths
New Mental Health Strategy Seeks to Curb Maternal Deaths
Study Finds Link Between Hip Fracture and Dementia Later On
Study Finds Link Between Hip Fracture and Dementia Later On
LUTS Associated With Poorer Cognition in Older Adults
LUTS Associated With Poorer Cognition in Older Adults
Skin Tags Linked to Metabolic Syndrome in Children
Skin Tags Linked to Metabolic Syndrome in Children
Lower Protein Intake In Midlife May Increase Mortality Risk
Lower Protein Intake In Midlife May Increase Mortality Risk
5 Things to Know: COVID-19 Vaccines for Immunocompromised People
5 Things to Know: COVID-19 Vaccines for Immunocompromised People
Desktop versie